Current regulatory approaches for accessing potential COVID-19 therapies

被引：0

作者：

Vesa Halimi

Armond Daci

Simona Stojanovska

Irina Panovska-Stavridis

Milena Stevanovic

Venko Filipce

Aleksandra Grozdanova

机构：

[1] Faculty of Pharmacy,Department of Pharmacy, Faculty of Medicine

[2] University Ss. Cyril and Methodius,undefined

[3] University of Prishtina,undefined

[4] University Clinic of Hematology,undefined

[5] Medical Faculty,undefined

[6] University Ss. Cyril and Methodius,undefined

[7] University Clinic of Infection diseases and febrile conditions,undefined

[8] Medical Faculty,undefined

[9] University Ss. Cyril and Methodius,undefined

[10] University Clinic for Neurosurgery,undefined

[11] Medical Faculty,undefined

[12] University Ss. Cyril and Methodius,undefined

来源：

Journal of Pharmaceutical Policy and Practice | / 13卷

关键词：

COVID-19; Regulatory; EMA; FDA; Clinical studies; Compassionate use; Clinical practice; Off-label use; Emergency use;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

This commentary aims to elaborate challenges in the regulatory approaches for accessing and investigating COVID-19 potential therapies either with off-label use, compassionate use, emergency use or for clinical trials. Since no therapies have been formally approved and completely effective and safe to date, the best clinical choice is acquired only after consistent and fair communication and collaboration between licensed clinicians, researchers, regulatory authorities, manufacturers and patients.

引用

共 50 条

[1] Current regulatory approaches for accessing potential COVID-19 therapies
Halimi, Vesa
Daci, Armond
Stojanovska, Simona
Panovska-Stavridis, Irina
Stevanovic, Milena
Filipce, Venko
Grozdanova, Aleksandra
JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2020, 13 (01)
[2] Current therapies under investigation for COVID 19: potential COVID-19 treatments
Weisberg, Ellen
Sattler, Martin
Yang, Priscilla L.
Parent, Alexander
Gray, Nathanael
Griffin, James D.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2020, 98 (08) : 483 - 489
[3] Potential specific therapies in COVID-19
Gul, Muhammad Hamdan
Htun, Zin Mar
Shaukat, Nauman
Imran, Muhammad
Khan, Ahmad
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2020, 14
[4] Cell therapy strategies for COVID-19: Current approaches and potential applications
Zaki, Mark M.
Lesha, Emal
Said, Khaled
Kiaee, Kiavash
Robinson-McCarthy, Lindsey
George, Haydy
Hanna, Angy
Appleton, Evan
Liu, Songlei
Ng, Alex H. M.
Khoshakhlagh, Parastoo
Church, George M.
SCIENCE ADVANCES, 2021, 7 (33)
[5] Evaluation of Current Therapies for COVID-19 Treatment
Sethi, Atin
Bach, Horacio
MICROORGANISMS, 2020, 8 (08) : 1 - 17
[6] Potential of regulatory T-cell-based therapies in the management of severe COVID-19
Stephen-Victor, Emmanuel
Das, Mrinmoy
Karnam, Anupama
Pitard, Bruno
Gautier, Jean-Francois
Bayry, Jagadeesh
EUROPEAN RESPIRATORY JOURNAL, 2020, 56 (03)
[7] Doxycycline as a potential partner of COVID-19 therapies
Malek, Alexandre E.
Granwehr, Bruno P.
Kontoyiannis, Dimitrios P.
IDCASES, 2020, 21
[8] COVID-19: Immunology, Immunopathogenesis and Potential Therapies
Bhardwaj, Asha
Sapra, Leena
Saini, Chaman
Azam, Zaffar
Mishra, Pradyumna K.
Verma, Bhupendra
Mishra, Gyan C.
Srivastava, Rupesh K.
INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2022, 41 (02) : 171 - 206
[9] Current and future therapeutical approaches for COVID-19
Duan, Yongtao
Yao, Yongfang
Kumar, Senthil Arun
Zhu, Hai-Liang
Chang, Junbiao
DRUG DISCOVERY TODAY, 2020, 25 (08) : 1545 - 1552
[10] Current Approaches to COVID-19: Therapy and Prevention
Dixit, Subhal B.
Zirpe, Kapil G.
Kulkarni, Atul P.
Chaudhry, Dhruva
Govil, Deepak
Mehta, Yatin
Jog, Sameer A.
Khatib, Khalid, I
Pandit, Rahul A.
Samavedam, Srinivas
Rangappa, Pradeep
Bandopadhyay, Susruta
Shrivastav, Om
Mhatre, Ujwala
INDIAN JOURNAL OF CRITICAL CARE MEDICINE, 2020, 24 (09) : 838 - 846

← 1 2 3 4 5 →